DE69928685D1 - Heilmittel und/oder vorbeugungsmittel gegen fettleibigkeit - Google Patents

Heilmittel und/oder vorbeugungsmittel gegen fettleibigkeit

Info

Publication number
DE69928685D1
DE69928685D1 DE69928685T DE69928685T DE69928685D1 DE 69928685 D1 DE69928685 D1 DE 69928685D1 DE 69928685 T DE69928685 T DE 69928685T DE 69928685 T DE69928685 T DE 69928685T DE 69928685 D1 DE69928685 D1 DE 69928685D1
Authority
DE
Germany
Prior art keywords
remedies
agents against
against gravity
prevention agents
therapeutic agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69928685T
Other languages
English (en)
Other versions
DE69928685T2 (de
Inventor
Masaaki Goto
Akihiro Tomoyasu
Kyoji Yamaguchi
Masahiko Kinosaki
Nobuaki Nakagawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daiichi Pharmaceutical Co Ltd
Original Assignee
Daiichi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Pharmaceutical Co Ltd filed Critical Daiichi Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DE69928685D1 publication Critical patent/DE69928685D1/de
Publication of DE69928685T2 publication Critical patent/DE69928685T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Organic Chemistry (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Seal Device For Vehicle (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Lubricants (AREA)
  • Production Of Liquid Hydrocarbon Mixture For Refining Petroleum (AREA)
DE69928685T 1998-09-17 1999-09-17 Heilmittel und/oder vorbeugungsmittel gegen fettleibigkeit Expired - Fee Related DE69928685T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP26300498 1998-09-17
JP26300498 1998-09-17
PCT/JP1999/005080 WO2000016795A1 (fr) 1998-09-17 1999-09-17 Agents pour la prevention et/ou le traitement de l'obesite

Publications (2)

Publication Number Publication Date
DE69928685D1 true DE69928685D1 (de) 2006-01-05
DE69928685T2 DE69928685T2 (de) 2006-08-24

Family

ID=17383564

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69928685T Expired - Fee Related DE69928685T2 (de) 1998-09-17 1999-09-17 Heilmittel und/oder vorbeugungsmittel gegen fettleibigkeit

Country Status (7)

Country Link
US (1) US6815417B1 (de)
EP (1) EP1121936B1 (de)
AT (1) ATE311197T1 (de)
AU (1) AU759409B2 (de)
CA (1) CA2342834A1 (de)
DE (1) DE69928685T2 (de)
WO (1) WO2000016795A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6902890B1 (en) 1999-11-04 2005-06-07 Diadexus, Inc. Method of diagnosing monitoring, staging, imaging and treating cancer
US8569240B2 (en) 2008-01-25 2013-10-29 Regeron, Inc. Methods of preventing or treating brain diseases
EP2255825A4 (de) * 2008-01-25 2011-09-14 Regeron Inc Zusammensetzung zur prävention oder behandlung von gehirnerkrankungen
US9060988B2 (en) 2011-07-09 2015-06-23 Tohoku University Method for treating pulmonary fibrosis using a pharmaceutical composition containing stanniocalcin 1 (STC1)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988003949A1 (en) * 1986-11-21 1988-06-02 Howard Florey Institute Of Experimental Physiology The cs protein of the corpuscles of stannius
US5837498A (en) 1994-03-08 1998-11-17 Human Genome Scienes, Inc. Corpuscles of stannius protein, stanniocalcin

Also Published As

Publication number Publication date
ATE311197T1 (de) 2005-12-15
AU759409B2 (en) 2003-04-17
DE69928685T2 (de) 2006-08-24
WO2000016795A1 (fr) 2000-03-30
EP1121936B1 (de) 2005-11-30
EP1121936A1 (de) 2001-08-08
CA2342834A1 (en) 2000-03-30
US6815417B1 (en) 2004-11-09
EP1121936A4 (de) 2004-11-17
AU5653299A (en) 2000-04-10

Similar Documents

Publication Publication Date Title
ATE297204T1 (de) Heilmittel für neurodegenerative krankheiten
ATE177949T1 (de) Kombinationstherapie zur prophylaxe und/oder behandlung benigner prostatahyperplasie
WO2002085303A3 (en) Substituted tetracycline compounds for the treatment of malaria
GB0225475D0 (en) Therapeutic agents
BR9912805A (pt) Composições farmacêuticas para a prevenção e para o tratamento de distúrbios do sistema nervoso central
DE60316779D1 (de) Thiadiazolylpiperazinderivate geeignet für die behandlung bzw. prävention von schmerzen
GB0223040D0 (en) Therapeutic compounds
EP1232757A4 (de) Mittel für erkrankungen assoziert mit knochensubstanzverlust
DE60016460D1 (de) Verwendungen und zusammenstellungen von nitratestern als sedativa
FI951856A0 (fi) Farmaseuttinen koostumus osteoporoosin hoitamiseksi
UA35567C2 (uk) Фармацевтичний препарат для лікування хворих з порушеннями функції коагуляції, спосіб лікування таких хворих, спосіб одержання фармацевтичного препарату
DE60002226D1 (de) Zusammensetzung zur vorbeugung und/oder behandlung von kreislaufstörungen, enthaltend l-carnitin derivate und ginkgo biloba extrakte
RS50148B (sr) Upotreba docetaksela za lečenje hepatoćelijskog karcinoma
DE69928685D1 (de) Heilmittel und/oder vorbeugungsmittel gegen fettleibigkeit
DE60142308D1 (de) Vorbeugungs- oder heilmittel gegen endometriose
CZ20011550A3 (cs) Opticky aktivní derivát pyridyl-4H-1,2,4-oxadiazinu, jeho použití při léčbě vaskulárních onemocnění a farmaceutické kompozice ho obsahující
BR9808299A (pt) O uso de levobupivacaìna ou ropivacaìna para o tratamento da enxaqueca
HUP0000110A2 (hu) Azaciklusos, azabiciklusos vagy tetrahidropiridinszármazékokat tartalmazó, fájdalom kezelésére alkalmas gyógyászati készítmények
BR0015781A (pt) Composição farmacêutica para tratamento de doenças associadas à diminuição de massa óssea
BR0116554A (pt) Composto, composição farmacêutica para o tratamento da angina ou hipertensão, processo, processo para o tratamento ou prevenção da angina ou hipertensão, composição do ingrediente farmaceuticamente ativo e composição farmacêutica para o tratamento ou prevenção da angina ou hipertensão
TWI262791B (en) 6-methoxy-2-naphthylacetic acid prodrugs
BR9915292A (pt) Associação, utilização de riluzol e composição farmacêutica.
DE69528068D1 (de) Conagenine zur prävention und behandlung von diarrhöe
ATE271867T1 (de) Behandlung der harninkontinenz und zusammenstellung dafür
HUP0301810A2 (hu) Anetol-ditioletion alkalmazása gyógyszer által kiváltott ín-toxicitás megelżzésénél és kezelésénél

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee